Confronting corporate power: addressing commercial determinants of health and the rising non-communicable disease epidemic in South-East Asia. [PDF]
BMJ Glob HealthBassi S +5 more
europepmc +1 more source
Rethinking revolving door research: a scoping review of methods and datasets used by non-academics to examine the revolving door. [PDF]
Global HealthJaenecke S, Lacy-Nichols J.
europepmc +1 more source
Australian sport policy and advocacy: an historical account of policy evolution, government involvement, and the advent of lobbying. [PDF]
Front Sports Act LivingMountifield C.
europepmc +1 more source
The power of people who use drugs as mass media influencers in changing public opinion during the global overdose epidemic. [PDF]
Subst Abuse Treat Prev PolicyJozaghi E +1 more
europepmc +1 more source
Community power in tobacco cessation: sustainable solutions for low- and middle-income countries. [PDF]
Ann Med Surg (Lond)Akhter J +4 more
europepmc +1 more source
The Application of Corporate Political Activity Taxonomies to Explore the Lobbying of Ultra-Processed Sugary Food and Drink Industries in Chile Comment on "Corporate Political Activity: Taxonomies and Model of Corporate Influence on Public Policy". [PDF]
Int J Health Policy ManagAravena-Rivas Y.
europepmc +1 more source
Commercial determinants of health: an approach for strengthening One Health interventions. [PDF]
Front Public HealthEbata A +4 more
europepmc +1 more source
A 10-year comparative analysis of medical and surgical specialty lobbying by physician professional organizations. [PDF]
Health Aff SchBouvette M +6 more
europepmc +1 more source
The tobacco industry at the health-environment nexus: a framing analysis of the UK 'disposable' e-cigarette ban. [PDF]
Health Promot IntLomngam P +3 more
europepmc +1 more source
Federal Lobbyist Spending to Influence 340B Drug Pricing Program Policy.
JAMA Netw OpenUrban C, Shore C, Desai S, Taylor L.
europepmc +1 more source